Skip to content
PubMed This is a summary of 131 peer-reviewed journal articles Updated
Acquired Immunodeficiency Syndrome

AIDS: A Patient Guide

At a Glance

AIDS is an advanced clinical stage of HIV, not an automatic terminal prognosis. Consistent antiretroviral therapy can suppress the virus, support immune recovery, and allow most people with HIV to live long, active lives; sustained undetectable levels prevent sexual transmission.

HIV (Human Immunodeficiency Virus) is a virus that gradually weakens the immune system by targeting the very cells responsible for defending your body against infection. If the virus is left untreated over many years, the immune system can become severely damaged, reaching a stage known as AIDS (Acquired Immunodeficiency Syndrome). While these terms were once associated with a terminal prognosis, the landscape of HIV care has been fundamentally transformed by modern medicine. Today, AIDS is understood as a clinical stage of infection. While an AIDS diagnosis remains part of your medical history, your immune function can recover and your prognosis can greatly improve through consistent treatment [1][2].

The biological mechanism of HIV involves the virus using your body’s immune cells to replicate itself, a process that leads to the depletion of these vital defenses. However, the standard of care, known as Antiretroviral Therapy (ART), effectively interrupts this cycle. By taking a daily regimen of medication, you can lower the amount of virus in your blood to suppressed levels. This durable viral suppression allows your immune system to recover and protects you from the illnesses that characterize advanced HIV [3][4].

Living with HIV today means managing a chronic condition. One of the most significant breakthroughs in this journey is the principle of U=U (Undetectable = Untransmittable). When the virus is suppressed to undetectable levels (generally defined as an HIV RNA viral load below 200 copies/mL) and maintained, it cannot be passed to sexual partners [5][6]. It is important to note that U=U applies specifically to sexual transmission; it does not prevent other sexually transmitted infections (STIs) or pregnancy, and it has not been established as zero-risk protection for sharing injection equipment or breastfeeding. Ongoing monitoring is essential, and you should contact your care team if your viral load rebounds. With early diagnosis and a commitment to treatment, most people living with HIV can expect to lead long, active lives.

Common questions in this guide

How are HIV and AIDS different?
HIV is a virus that attacks immune cells. AIDS is the advanced clinical stage of HIV infection that can occur when untreated infection severely damages the immune system over time.
Can treatment help my immune system recover after an AIDS diagnosis?
Yes. Daily antiretroviral therapy, or ART, can reduce HIV in the blood to suppressed levels, allowing the immune system to recover and lowering the risk of illnesses linked with advanced HIV. An AIDS diagnosis remains part of your medical history, so ongoing care and monitoring are important.
What does U=U mean if I have HIV?
U=U means Undetectable equals Untransmittable. When treatment keeps the HIV RNA viral load below 200 copies per milliliter and this level is maintained, HIV is not passed through sex. U=U does not prevent other sexually transmitted infections or pregnancy, and zero-risk protection has not been established for sharing injection equipment or breastfeeding.
How does antiretroviral therapy work?
ART is a daily regimen of medicines that interrupts HIV’s ability to make more copies of itself. This lowers the amount of virus in the blood, supports immune recovery, and helps protect against illnesses associated with advanced HIV.
What is the outlook after an AIDS diagnosis?
With early diagnosis and consistent treatment, most people living with HIV can expect to lead long, active lives. Ongoing viral-load monitoring helps the care team respond if the virus rebounds, while your individual outlook depends on your health history and response to treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current results, what is the immediate goal for my immune system recovery?
  2. 2.What is the best way for us to communicate between appointments if I have concerns about symptoms or side effects?
  3. 3.How will we coordinate my HIV care with other health screenings or conditions I may have?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (6)
  1. 1

    AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan.

    Lee CY, Tseng YT, Lin WR, et al.

    BMC infectious diseases 2018; (18(1)):352 doi:10.1186/s12879-018-3251-1.

    PMID: 30055564
  2. 2

    Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study.

    Shoko C, Chikobvu D, Bessong PO

    Pakistan journal of biological sciences : PJBS 2020; (23(4)):542-551 doi:10.3923/pjbs.2020.542.551.

    PMID: 32363840
  3. 3

    Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.

    Lecher S, Williams J, Fonjungo PN, et al.

    MMWR. Morbidity and mortality weekly report 2016; (65(47)):1332-1335 doi:10.15585/mmwr.mm6547a2.

    PMID: 27906910
  4. 4

    Five-Year Immune Recovery After ART Initiation Among PLWH Aged ≥15 Years with Baseline Immunosuppression - China, 2013-2024.

    Geng Y, Jia H, Guan Y, et al.

    China CDC weekly 2026; (8(25)):772-779 doi:10.46234/ccdcw2026.125.

    PMID: 42433220
  5. 5

    Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

    Rodger AJ, Cambiano V, Bruun T, et al.

    Lancet (London, England) 2019; (393(10189)):2428-2438 doi:10.1016/S0140-6736(19)30418-0.

    PMID: 31056293
  6. 6

    Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

    , Lundgren JD, Babiker AG, et al.

    The New England journal of medicine 2015; (373(9)):795-807 doi:10.1056/NEJMoa1506816.

    PMID: 26192873

This page is for informational purposes only and does not constitute medical advice about HIV or AIDS. Discuss your test results, treatment, and viral-load monitoring with your HIV care team.

Get notified when new evidence is published on AIDS.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.